Toll-Like Receptor 9 Stimulation Can Induce I Kappa B Zeta Expression And Igm Secretion In Chronic Lymphocytic Leukemia Cells

Chronic lymphocytic leukemia cells strongly depend on external stimuli for their survival. Both antigen receptor and co-stimulatory receptors, including Toll-like receptors, can modulate viability and proliferation of leukemic cells. Toll-like receptor ligands, and particularly the TLR9 ligand CpG, mediate heterogeneous responses in patients' samples reflecting the clinical course of the subjects. However, the molecular framework of the key signaling events underlying such heterogeneity is undefined. We focused our studies on a subset of chronic lymphocytic leukemia cases characterized by expression of CD38 and unmutated immunoglobulin genes, who respond to CpG with enhanced metabolic cell activity. We report that, while CpG induces NFKBIZ mRNA in all the samples analyzed, it induces the I kappa B zeta protein in a selected group of cases, through an unanticipated post-transcriptional mechanism. Interestingly, I kappa B zeta plays a causal role in sustaining CpG-induced cell viability and chemoresistance, and CpG stimulation can unleash immunoglobulin secretion by I kappa B zeta-positive malignant cells. These results identify and characterize I kappa B zeta as a marker and effector molecule of distinct key pathways in chronic lymphocytic leukemia.